SEED Innovations sees progress across its portfolio

  • SEED Innovations investee company Eurox ties up European distribution deal
  • FastForward Innovations’ ups stake in Little Green Pharma after being ‘really impressed’ by firm
FastForward Innovations Limited - FastForward Innovations targets significant upside with portfolio of early stage tech firms

Quick facts: SEED Innovations Ltd


View company profile

SEED Innovations Ltd’s investment focus leans towards capitalising on the company’s knowledge in the cannabinoid wellness and medical cannabis arenas.

As the only AIM-quoted investor with direct exposure to pharmaceutical and medical cannabis, SEED continues to demonstrate its expertise in the sector, notably with two of its portfolio assets selling for a combined value of over $1bn.

SEED is focused on investing in a balance of early-stage opportunities that have an upcoming investment catalyst, and more mature investments that offer liquidity in the near term.

17 Aug 2021

() portfolio company Eurox Group has signed a distribution agreement with Materia Deutschland, a processor and distributor of medical cannabis and CBD wellness products across Europe.

Materia will become one of Eurox’s selected distribution partners for its medicinal cannabis extracts, SEED added.

Ed McDermott SEED’s chief executive, said: “We are very pleased to see Eurox-branded products, that are all locally produced in Germany, being utilised in a distribution agreement with Materia.

“Over the coming weeks and months, we expect to see a number of distribution avenues through pharmaceutical distributors and medical cannabis distributors for the ‘made in Germany’ Eurox-brand whilst they continue to grow their range of products.

Read more

17 Aug 2021

() said Eurox Group, in which it has an 8.85% stake, has launched its own brand of “made in Germany” full-spectrum medical cannabis extracts.

SEED said the launch took place ahead of schedule and represents a milestone for Eurox.

Read more

03 Aug 2021

(), an investor within the medical cannabis, health and wellness space, said it participated in the latest US$9.7mln financing round by its portfolio company, (, ).

SEED has invested a further GBP220,000 in the Canadian CBD and hemp wellness brand at a price of C$0.90 per share.

Read more

11 Jun 2021

‘s () Ed McDermott and Alfredo Pascual join Proactive London’s Katie Pilbeam to explain why they purchased a further 1.17mln shares in its portfolio firm (LGP). This was done through the Australian Stock Exchange at an average price of A$0.655 each which means it now holds shares equivalent to around 2% of LGP’s share capital.

McDermott says ‘they are doing exactly want we want them to do, hence we felt it was a good time to start buying, markets are a little softer at the moment so we took advantage of that’. Pascual adds, ‘we identified a listed company that is very well run and is growing rapidly and is constantly achieving new milestones’.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash…


Seed Innovations is committed to living better for longer and healthy…

So what’s in a name and a memorable ticker? Fast Forward Innovations has rebranded into Seed Innovations Limited (LON:SEED), and the business proposition is investment in emerging global health trends and the generation of attractive investment returns.

Chief executive Ed McDermott tells…

4 weeks ago

3 min read


Please enter your comment!
Please enter your name here